Mostrar el registro sencillo del ítem

dc.contributor.authorTirado Pérez, Irina Suleyspa
dc.contributor.authorZárate Vergara, Andrea Carolinaspa
dc.date.accessioned2020-10-27T14:19:26Z
dc.date.available2020-10-27T14:19:26Z
dc.date.issued2018-07-06
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.urihttp://hdl.handle.net/20.500.12749/9962
dc.description.abstractLa anemia falciforme es una hemoglobinopatía estructural de origen genético, se caracteriza por la presencia de hemoglobina falciforme. La hemoglobina anormales inestable, tiende a polimerizarse y puede ocluirla microcirculación, produciendo manifestaciones multisistémicas tanto agudas como crónicas relacionándose con mayor riesgo de contraer infecciones. Objetivo: Describir la información del tema expuesto resaltando los aspectos más relevantes como diagnóstico y tratamiento. Metodología: Se efectuó una revisión bibliográfica con búsqueda electrónica en las siguientes bases de datos: PubMed, MEDLINE, Medscape, Scopus; y se incluyó diferentes tipos de artículo (artículos originales, revisiones de temas y guías de manejo) que abordaran la anemia de células falciformes en pediatría. Resultados: Se obtuvo una revisión de 22 artículos, donde se describe el tema de anemia de células falciformes, pautas y tratamientos basados en el manejo y control de los síntomas; se evidencia que el uso de ecografía doppler transcraneal y las transfusiones demostraron ser estrategias preventivas o de tratamiento eficaces para las complicaciones relacionadas con esta patología en los niños. Conclusiones: En Colombia, la prevalencia de la patología no se encuentra establecida. Por otra parte, las principales manifestaciones se relacionan con complicaciones de vaso-oclusión en los diferentes órganos y la asplenia funcional, la cual predispone a cuadros infecciosos. [Tirado-Pérez IS, Zárate Vergara AC. Anemia de células falciformes en pediatría: Revisión de la literatura. Revisión de tema. MedUNAB2017-2018; 20(3): 374-382]spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/2378/2862
dc.relation/*ref*/Maakaron J, Taher A. Sickle Cell Anemia. Medscape article. [Internet]. 2015. [Updated: Oct 15, 2015]. Disponible en: http://emedicine.medscape.com/article/205926-overview 2. Quintero M, Jiménez A. Anemia De Células Falciformes. Revista Gastrohnup. 2012; 14(2):Sup1:S27-S35. 3. Ayala A, González H, David G. Anemia de células falciformes: una revisión. Salud Uninorte. 2016; 32(3):513-527. 4. Kavanagh P, Sprinz P, Vinci S, Bauchner H, Wang C. Management of Children With Sickle Cell Disease: A Comprehensive Review of the Literature. Pediatrics. 2011; 128(6):1552-1574. 5. Lemanek K, Ranalli M, Lukens C. A randomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol. 2009; 34(10):1091–1096. 6. McClellan C, Schatz J, Puffer E, Sanchez C, Stancil M, Roberts C. Use of handheld wireless technology for a home-based sickle cell pain management protocol. J Pediatr Psychol. 2009; 34(5):564–573. 7. Nolan V, Zhang Y, Lash T, Sebastiani P, Steinberg M. Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a casecrossover study. Br J Haematol. 2008; 143(3):433–8. 8. Meier E, Miller J. Sickle cell disease in children. Drugs. 2012; 72(7):895-906. 9. Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sickle cell disease. J Thromb Haemost. 2017; 15(7):1307–16. 10. Cervera Á, Cela E. Anemia falciforme. Manejo en Atención Primaria. Rev Pediatr Aten Primaria. 2007; 9(36):649-68. 11. Driscoll M, Hurlet A, Styles L, Mckie V, Files B, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003; 101(6):2401-2404. 12. Yazdanbakhsh K, Shaz B, Hillyer C. Immune regulation of sickle cell alloimmunization. ISBT Science Series. 2017; 12(1):248–253. Disponible en: https://doi.org/10.1111/voxs.12296. 13. National Heart, Lung, and Blood Institute. Management and therapy of sickle cell disease. 4ed. Bethesda. [Internet]. 2002. [Revisado el: Oct 15, 2015]. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf 14. American Academy of Pediatrics, Section on Hematology/Oncology and Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics. 2002; 109(3):526-35. 15. Adams R, McKie V, Hsu L, Files B, Vichinsky E, et al. Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography. N Engl J Med. 1998; 339:5-11. 16. Yawn B, Buchanan G, Afenyi-Annan A, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014; 312(10):1033-1048. Disponible en: https://doi.org/10.1001/Jama.2014.10517. 17. Adams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, et al. Stroke and Conversion To High Risk In Children Screened With Transcranial Doppler Ultrasound During The STOP Study. Blood. 2004; 103(10):3689-3694. 18. Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000; 342(25):1855–1865. 19. Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?. Ann Emerg Med. 1999; 34(1):64–69. 20. Smith K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004; 103(2):422–427. 21. Gil K, Carson J, Porter L, Ready J, Valrie C, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003; 28(5):363–373. 22. Jacob E, Miaskowski C, Savedra M, Beyer J, Treadwell M, Styles L. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol. 2003; 25(4):307–311.
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/2378
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 20 Núm. 3 (2018): Diciembre - Marzo de 2018: Educación, Tabaquismo, Accidente Ofídico; 374-382
dc.titleAnemia de células falciformes en pediatría: revisión de la literatura
dc.title.translatedSickle cell anemia in pediatrics: literature revieweng
dc.title.translatedAnemia falciforme em pediatria: Revisão da literaturaport
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.programPregrado Medicina
dc.type.driverinfo:eu-repo/semantics/article
dc.type.localArtículospa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.subject.keywordsAnemia, Hemolyticeng
dc.subject.keywordsAnemia, Sickle Celleng
dc.subject.keywordsHemoglobin, Sickleeng
dc.subject.keywordsPediatricseng
dc.subject.keywordsHemoglobin SC Diseaseeng
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.type.hasversionInfo:eu-repo/semantics/publishedVersion
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.relation.referencesMaakaron J, Taher A. Sickle Cell Anemia. Medscape article.[Internet].2015.[Updated:Oct15,2015]. Disponible http://emedicine.medscape.com/article/205926-overview
dc.relation.referencesQuintero M, Jiménez A. Anemia De Células Falciformes. Revista Gastrohnup. 2012; 14(2):Sup1:S27-S35
dc.relation.referencesAyalaA,GonzálezH,DavidG.Anemiadecélulas falciformes:unarevisión.SaludUninorte.2016; 32(3):513-527
dc.relation.referencesKavanagh P, Sprinz P, Vinci S, Bauchner H, Wang C. Management of Children With Sickle Cell Disease: A Comprehensive Review of th eLiterature.Pediatrics. 2011; 128(6):1552-1574
dc.relation.referencesLemanekK,RanalliM,LukensC.Arandomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol. 2009; 34(10):1091–1096
dc.relation.referencesMcClellan C, Schatz J, Puffer E, Sanchez C, Stancil M, Roberts C. Use of handheld wireless technology for a home-based sickle cell pain management protocol. J Pediatr Psychol. 2009; 34(5):564–573
dc.relation.referencesNolan V, Zhang Y, Lash T, Sebastiani P, Steinberg M. Association between wind speed and the occurrence of sicklecellacutepainfulepisodes:resultsofa casecrossover study. Br J Haematol. 2008; 143(3):433–8
dc.relation.referencesMeier E, Miller J. Sickle cell disease in children. Drugs. 2012; 72(7):895-906
dc.relation.referencesSparkenbaugh E, Pawlinski R. Prothrombotic aspects of sicklecelldisease.JThrombHaemost.2017; 15(7):1307–16
dc.relation.referencesCerveraÁ,CelaE.Anemiafalciforme.Manejoen Atención Primaria. Rev Pediatr Aten Primaria. 2007; 9(36):649-68
dc.relation.referencesDriscoll M, Hurlet A, Styles L, Mckie V, Files B, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003; 101(6):2401-2404
dc.relation.referencesYazdanbakhsh K, Shaz B, Hillyer C. Immune regulation of sickle cell alloimmunization. ISBT Science Series. 2017; 12(1):248–253.Disponibleen:https://doi.org/10.1111/ voxs.12296
dc.relation.referencesNational Heart, Lung, and Blood Institute. Management andtherapyofsicklecelldisease.4ed.Bethesda. [Internet]. 2002. [Revisado el: Oct 15, 2015]. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pd
dc.relation.referencesAmericanAcademyofPediatrics,Sectionon Hematology/OncologyandCommitteeonGenetics. Health supervision for children with sickle cell disease. Pediatrics. 2002; 109(3):526-35
dc.relation.referencesAdams R, McKie V, Hsu L, Files B, Vichinsky E, et al. Prevention of a First Stroke by Transfusions in Children withSickleCellAnemiaandAbnormalResultson Transcranial Doppler Ultrasonography. N Engl J Med. 1998; 339:5-1
dc.relation.referencesYawn B, Buchanan G, Afenyi-Annan A, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014; 312(10):1033-1048.Disponibleen:https://doi.org/ 10.1001/Jama.2014.10517
dc.relation.referencesAdams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, et al. Stroke and Conversion To High Risk In Children Screened With Transcranial Doppler Ultrasound During The STOP Study. Blood. 2004; 103(10):3689-3694
dc.relation.referencesVichinsky E, Neumayr L, Earles A, Williams R, Lennette E, et al. Causes and outcomes of the acute chest syndrome insicklecelldisease.NEnglJMed.2000; 342(25):1855–1865
dc.relation.referencesMorris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?. Ann Emerg Med. 1999; 34(1):64–69
dc.relation.referencesSmith K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004; 103(2):422–427
dc.relation.referencesGil K, Carson J, Porter L, Ready J, Valrie C, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003; 28(5):363–373
dc.relation.referencesJacob E, Miaskowski C, Savedra M, Beyer J, Treadwell M, Styles L. Management of vaso-occlusivepainin children with sickle cell disease. J Pediatr Hematol Oncol. 2003; 25(4):307–311
dc.contributor.cvlacTirado Pérez, Irina Suley [0001553010]
dc.contributor.cvlacZárate Vergara, Andrea Carolina [0001535059]
dc.contributor.googlescholarZárate Vergara, Andrea Carolina [xhlO9JQAAAAJ&hl=es&oi=ao]
dc.contributor.orcidTirado Pérez, Irina Suley [0000-0002-9995-3287]
dc.contributor.orcidZárate Vergara, Andrea Carolina [0000-0001-8716-7097]
dc.subject.lembCiencias médicas
dc.subject.lembCiencias de la salud
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.description.abstractenglishSickle cell anemia is a structural hemoglobinopathy of genetic origin, characterized by the presence of sickle hemoglobin. The unstable abnormal hemoglobin tends to polymerize and can occlude the microcirculation, producing both acute and chronic multisystemic manifestations associated with a higher risk of contracting infections. Objective: Describe the information on the exposed topic highlighting the most relevant aspects such as diagnosis and treatment. Methodology: A bibliographic review was carried out with an electronic search in the following databases: PubMed, MEDLINE, Medscape, Scopus; and different types of articles were included (original articles, topic reviews and management guides) that addressed sickle cell anemia in pediatrics. Results: A review of 22 articles was obtained, which describes the topic of sickle cell anemia, guidelines and treatments based on the management and control of symptoms; it is evidenced that the use of transcranial Doppler ultrasound and transfusions proved to be effective preventive or treatment strategies for complications related to this pathology in children. Conclusions: In Colombia, the prevalence of the pathology has not been established. On the other hand, the main manifestations are related to vaso-occlusion complications in the different organs and functional asplenia, which predisposes to infectious conditions. [Tirado-Pérez IS, Zárate Vergara AC. Sickle Cell Anemia in Pediatrics: Review of the Literature. Topic review. MedUNAB2017-2018; 20 (3): 374-382]eng
dc.subject.proposalAnemia hemolítica
dc.subject.proposalAnemia de células falciformes
dc.subject.proposalHemoglobina falciforme
dc.subject.proposalPediatría
dc.subject.proposalEnfermedad de la hemoglobina SC
dc.identifier.doi10.29375/01237047.2378
dc.type.redcolhttp://purl.org/redcol/resource_type/ART
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 2.5 Colombia